Evidence map›Paper›PMID 33175600›Full record

Trial reportHuman vaccines & immunotherapeutics2021

Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable

Michael Horn, Ulrich Behre, Magali Traskine, Kurt Dobbelaere, Dorota Borys

Registry-linked trialOpen access · hybridAbstract readClinical Trial, Phase IMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01485406 (Safety and Immunogenicity Study of GSK Biologicals' Pneumococcal Vaccine 2830930A When Administered as a Single Dose in Healthy Toddlers Aged 12-23 Months), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01485406 phase1completednot on this map

Safety and Immunogenicity Study of GSK Biologicals' Pneumococcal Vaccine 2830930A When Administered as a Single Dose in Healthy Toddlers Aged 12-23 Months

TypeinterventionalSponsorGlaxoSmithKlineRan2011 to 2012Enrolled61ConditionsInfections, StreptococcalArmsPneumococcal vaccine GSK2830930A, Synflorix™
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Michael HornPediatric Office, Schönau Am Königssee, Germany.ORCID 0000-0002-4699-5969
Ulrich BehrePrivate Practice, Kehl, Germany.
Magali TraskineHPV, Hepatitis and Pneumococcal Vaccines, Clinical R&D, GSK, Wavre, Belgium.
Kurt DobbelaereHPV, Hepatitis and Pneumococcal Vaccines, Clinical R&D, GSK, Wavre, Belgium.ORCID 0000-0002-5426-2626
Dorota BorysHPV, Hepatitis and Pneumococcal Vaccines, Clinical R&D, GSK, Wavre, Belgium.ORCID 0000-0001-9704-8462
Office of Education · USUniversity of Applied Sciences Kehl · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a stepping stone toward evaluation in infants, the safety and immunogenicity of an investigational 12-valent pneumococcal non-typeable

Indexed as

Haemophilus influenzaePneumococcal InfectionsAntibodies, BacterialChild, PreschoolGermanyHumansImmunogenicity, VaccineInfantPneumococcal VaccinesVaccines, ConjugateAntibodies, BacterialPneumococcal VaccinesVaccines, Conjugatebooster doseimmunogenicityPHiD-CVPneumococcal conjugate vaccinesafetytoddlers

Identifiers

PMID33175600
PMCPMC8078718
OpenAlexW3099589721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.